r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

AS

Andrew J. Schwab

Insider · Director · CAMP

Andrew J. Schwab files insider transactions with the SEC as a director of Camp4 Therapeutics (CAMP). We hold 8 disclosed purchases and sales filed since 20 February 2014, 8 of them in the last 90 days.

  • Files forCAMP
  • Disclosed buys and sells8 in all, 8 in the last 90 days
  • Last disclosure31 August 2026

Positions held

16 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 October 2024 — 27 August 2026Director · Camp4 Therapeutics (CAMP)16 Form 4 lines · source: SEC Form 4
  • Filed 18 August 2023 — 20 August 2026Director and 10% owner · Skye Bioscience (SKYE)35 Form 4 lines · source: SEC Form 4
  • Filed 2 November 2021 — 1 July 202510% owner · Entrada Therapeutics (TRDA)17 Form 4 lines · source: SEC Form 4
  • Filed 23 February 2023 — 24 August 202310% owner · Enliven Therapeutics (ELVN)5 Form 4 lines · source: SEC Form 4
  • Filed 7 March 2023 — 7 March 202310% owner · Rallybio (RLYB)1 Form 4 line · source: SEC Form 4
  • Filed 24 February 2023 — 24 February 202310% owner · CinCor Pharma (CINC)3 Form 4 lines · source: SEC Form 4
  • Filed 30 November 2022 — 30 November 202210% owner · Akouos (AKUS)2 Form 4 lines · source: SEC Form 4
  • Filed 3 December 2021 — 18 August 202210% owner · Pear Therapeutics (PEAR)10 Form 4 lines · source: SEC Form 4
  • Filed 16 November 2021 — 16 November 202110% owner · Vor Biopharma (VOR)2 Form 4 lines · source: SEC Form 4
  • Filed 2 April 2018 — 14 December 202010% owner · Homology Medicines (FIXX)9 Form 4 lines · source: SEC Form 4
  • Filed 29 October 2019 — 10 December 202010% owner · Cabaletta Bio (CABA)6 Form 4 lines · source: SEC Form 4
  • Filed 16 October 2020 — 30 November 2020Co-CEO · 5:01 Acquisition (FVAM)5 Form 4 lines · source: SEC Form 4
  • Filed 11 November 2020 — 11 November 202010% owner · IDEAYA Biosciences (IDYA)3 Form 4 lines · source: SEC Form 4
  • Filed 26 May 2020 — 26 May 202010% owner · scPharmaceuticals (SCPH)1 Form 4 line · source: SEC Form 4
  • Filed 27 June 2019 — 28 June 201910% owner · Arvinas (ARVN)4 Form 4 lines · source: SEC Form 4
  • Filed 18 February 2014 — 3 March 2014Director and 10% owner · Flexion Therapeutics (FLXN)5 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.